CTN :39986166
01 May, 2025
NA
Tender For supply of ketamine hcl 50 mg per ml 2 ml inj , an cl
ass="text-red-selected">vit
aminan> b complex with
a minimum concentr
ation of vit b1 5mg vit b6 3mg
and vit b12 5mcg ther
apeutic t
ab c
ap , diclofen
ac sr 100 mg t
ab , t
ab pr
amipexole 0 point 25 mg , povidone iodine solution 5 percent bottle of 100 ml , t
ab epleronone 25 mg , t
ab ol
anz
apine 10mg , syp multi
an class="text-red-selected">vitaminan> drops with constituents h
aving vit
a vit b1 b2 b6 vit c vit d bottle of 15ml os
ages
as per recommended d
aily
allow
ances , t
ab rosuv
ast
atin 20 mg , diclofen
ac diethyl
amine 2 point 32 percent spr
ay for tofic
al use , inj phytomen
adione vit k 1 mg per 0 point 5 ml , inj esmolol 100 mg 10ml , t
ab r
abepr
azole 20 mg , inj benz
athine penicillin i p 600000 i u , t
ab trimet
azidine mr 35 mg , t
ab etoricoxib 120 mg , t
ab indometh
acin 75 mg sr t
ab , t
ab ketorol
ac 10mg t
ab , t
ab tr
am
adol hcl 50 mg , succinylchloline chloride 50 mg per ml 2 ml inj , t
ab dex
ameth
asone 0 point 5 mg , inj pr
alidoxine 500 mg per 20ml , t
ab clof
azimine 100mg , g
atiflox
acin 0 point 3 percent eye drop bott of 5 ml , t
ab trihexyphenidyl hcl 2 mg , t
ab eth
amsyl
ate 250mg , g
amm
a benzene hex
achloride 1 percent w by v cetrimide 0 point 1 percent w by v in
alcoholic solution , ciproflox
acin hcl 0 point 3 perent plus dex
ameth
asone 0 point 1 percent bott of 5ml , t
ab glyceryl trinitr
ate cr 2 point 6 mg , t
ab thyroxine sodium 75 mcg , t
ab voglibose 0 point 3 mg , t
ab digoxin 0 point 25 mg , t
ab clonidine 100mcg , bisoprolol 5 mg t
ab , hum
an insulin
an
alogue gl
argine inj 100 iu per ml recombin
ant dn
a origin 300 iu dispos
able pen with 5 needles per pen , t
ab nebivolol 50 mg ,
antibiotic ointment e
ach gm cont
aining polymyxin b sulph
ate 5000 units zinc b
acitr
acin 400 units neomycin sulph
ate 3400 units 5gm ointment , t
ab minocycline 100 mg , t
ab p
ar
aform
aldehyde , t
ab
antisp
asmodic cont
aining mefen
amic
acid 250 mg
and dicyclomine hcl 10mg , l
actic
acid b
acillus s
achet , hydrocortisone enem
a 10 percent w by w , t
ab bis
acodyi 5mg , liquid p
ar
affin in bottle of 100 ml , misoprostrol 25 mcg t
ab , t
ab isoxsuprine 10mg , estr
adiol v
aler
ate 2mg t
ab p
ack of 28 , sevel
amer 400mg t
ab , ciproflox
acin hcl 0 point 3 percent tube of 5 gm , cyclopentol
ate hcl 1 percent opth soln bottle of 5 ml , cre
am lulicon
azole tube of 15 gm , dex
ameth
asone sodium phosph
ate 1 percent
and tobr
amycin 0 point 3 percent w by w oint tube of 3 point 5gm , beclometh
asone dipropion
ate n
as
al spr
ay 50 mcg per dose metered dose 150 units , chlorprom
azine 25mg t
ab , t
ab
amisulpride 200mg , dextrose 50 percent 25 ml inj , dextrose inj 25 percent 25 ml inj , multi vit inj iv 2 10 ml with minimum constituents h
aving thi
amine b1 30mg per ml pyridoxine b6 30mg per ml
and b12 cy
anocob
al
amin 300 mcg per ml , c
aps
ac
ain gel tube of 20 gm , leflunomide t
ab 10 mg , nitrofur
antoin 100 mg t
ab , eye drop brimonidine 0 point 2 percent plus brinzol
amide 1 percent bottle of 5 ml , inj nitroglycerine 5 mg , t
ab sem
aglutide 3 mg , t
ab misoprostol 200mcg , inj tet
anus toxoid purified
absorbed rubber c
apped vi
al of 5 ml 10 doses , t
ab n
atur
al micronised progesterone 200mg , t
ab esomepr
azole 40 mg plus levosulpride 75 mg , s
almeterol 25 mcg plus flutic
asone 250 mcg
autoh
aler bid det
ails/ 2 / 58